14.58

0.90% 0.09

Benitec Biopharma Inc (BNTC)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$14.49

Aprire:

$14.89

Volume 24 ore:

26,425

Relative Volume:

0.57

Capitalizzazione di mercato:

$346.85M

Reddito:

$59,000

Utile/perdita netta:

$-21.81M

Rapporto P/E:

-1.3313

EPS:

-10.9518

Flusso di cassa netto:

$-18.07M

1 W Prestazione:

+12.55%

1M Prestazione:

+50.72%

6M Prestazione:

+79.39%

1 anno Prestazione:

+181.70%

Intervallo 1D:

$14.14

$15.01

Intervallo di 1 settimana:

$11.99

$15.01

Portata 52W:

$4.75

$15.01

Benitec Biopharma Inc Stock (BNTC) Company Profile

Nome

Benitec Biopharma Inc

Settore

Healthcare (1172)

Industria

Biotechnology (680)

Telefono

(510) 780-0819

Indirizzo

3940 TRUST WAY, HAYWARD, CA

Dipendente

Cinguettio

@BenitecLtd

Prossima data di guadagno

2024-11-11

Ultimi documenti SEC

BNTC's Discussions on Twitter

Confronta BNTC con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BNTC Benitec Biopharma Inc	14.50	346.85M	59,000	-21.81M	-18.07M	-10.95
VRTX Vertex Pharmaceuticals Inc	501.07	130.96B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	682.40	75.53B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	580.02	35.07B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	240.96	31.72B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	252.33	26.76B	3.32B	-860.46M	-1.04B	-8.32

Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-16	Iniziato	H.C. Wainwright	Buy
2024-12-13	Iniziato	Robert W. Baird	Outperform
2024-10-16	Iniziato	Oppenheimer	Outperform
2024-09-12	Iniziato	Guggenheim	Buy
2024-07-22	Iniziato	Leerink Partners	Outperform
2024-06-13	Iniziato	Piper Sandler	Overweight
2020-10-05	Downgrade	Ladenburg Thalmann	Buy → Neutral
2020-04-20	Iniziato	Ladenburg Thalmann	Buy
2016-02-26	Downgrade	Maxim Group	Buy → Hold
2015-12-31	Reiterato	Maxim Group	Buy
2015-09-16	Reiterato	Maxim Group	Buy

Mostra tutto

Benitec Biopharma Inc Borsa (BNTC) Ultime notizie

08:02 AM

BenitecAnother Biopharma Rocket - Barchart

08:02 AM

Mar 12, 2025

Benitec Biopharma (NASDAQ:BNTC) Shares Cross Above 50-Day Moving Average – Here’s Why - Defense World

Mar 12, 2025

Benitec BiopharmaGetting To The Roots Of Oculopharyngeal Muscular Dystrophy - RTTNews

Mar 12, 2025

Mar 11, 2025

Benitec Biopharma stock soars to 52-week high of $13.32 By Investing.com - Investing.com Australia

Mar 11, 2025

Benitec Biopharma stock soars to 52-week high of $13.32 - Investing.com India

Mar 11, 2025

Mar 10, 2025

Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Mar 10, 2025

Mar 04, 2025

How to Take Advantage of moves in (BNTC) - Stock Traders Daily

Mar 04, 2025

Feb 27, 2025

Antisense & RNAi Therapeutics Market to Set Remarkable Growth - openPR

Feb 27, 2025

Feb 26, 2025

Benitec Biopharma to Participate in Upcoming Conferences in March - GlobeNewswire

Feb 26, 2025

Reviewing NexImmune (NASDAQ:NEXI) & Benitec Biopharma (NASDAQ:BNTC) - Defense World

Feb 26, 2025

Feb 25, 2025

Benitec Biopharma's SWOT analysis: gene therapy stock shows promise amid trials By Investing.com - Investing.com South Africa

Feb 25, 2025

Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise amid trials - Investing.com India

Feb 25, 2025

Benitec Biopharma's SWOT analysis: gene therapy stock shows promise amid trials - Investing.com

Feb 25, 2025

Feb 23, 2025

Wall Street Analysts Predict a 127.26% Upside in Benitec Biopharma (BNTC): Here's What You Should Know - MSN

Feb 23, 2025

HC Wainwright Reiterates “Buy” Rating for Benitec Biopharma (NASDAQ:BNTC) - Defense World

Feb 23, 2025

Feb 21, 2025

(BNTC) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Feb 21, 2025

H.C. Wainwright maintains $28 target on Benitec BioPharma stock By Investing.com - Investing.com UK

Feb 21, 2025

Feb 20, 2025

Benitec Biopharma (BNTC) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance

Feb 20, 2025

Feb 19, 2025

Citizens JMP maintains Benitec stock with $18 target By Investing.com - Investing.com Australia

Feb 19, 2025

Citizens JMP maintains Benitec stock with $18 target - Investing.com India

Feb 19, 2025

Feb 18, 2025

Benitec Biopharma (NASDAQ:BNTC) Announces Earnings Results, Beats Estimates By $0.19 EPS - MarketBeat

Feb 18, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Rating of “Buy” from Analysts - Defense World

Feb 18, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Feb 18, 2025

Feb 17, 2025

Benitec Biopharma (NASDAQ:BNTC) Stock Price Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat

Feb 17, 2025

Feb 16, 2025

Benitec Biopharma Inc. Announces Q4 2024 Financial Results and Operational Update - Defense World

Feb 16, 2025

Feb 15, 2025

Benitec Biopharma Announces Acceptance of Late- Breaking - GlobeNewswire

Feb 15, 2025

Feb 14, 2025

Benitec presents new gene therapy data at MD conference By Investing.com - Investing.com Canada

Feb 14, 2025

Benitec presents new gene therapy data at MD conference - Investing.com India

Feb 14, 2025

Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update - TradingView

Feb 14, 2025

Benitec Biopharma Inc. Announces Late-Breaking Presentation on BB-301 Phase 1b/2a Clinical Study for Oculopharyngeal Muscular Dystrophy at 2025 MDA Conference - Nasdaq

Feb 14, 2025

Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference - The Manila Times

Feb 14, 2025